CHIASMA INC.DL-,01 WKN: A14WW4 ISIN: US16706W1027 Kürzel: CXS Forum: Aktien Thema: Hauptdiskussion

Doch! Allerdings nur mit kleiner Pos drin. Ist eher Nebenkriegsschauplatz.

Niemand hier 🤣🤣🤣

4,20☝️

Erneuter Kauf bei 3,20. Hoffe ich bereue meine Position nicht.

https://www.nasdaq.com/press-release/chiasma-announces-fda-acceptance-of-mycapssar-new-drug-application-resubmission-2020

Langsam Mal auf Juni vorbereiten. Derzeit ja sehr ruhig hier...

Ihr verpasst hier was. IMO

Aufgestockt

Bin hier mit ner ersten Position dabei.

Hallo👋 Noch jemand da? 🧐 Chiasma Provides Update On Ongoing Mycapssa® Phase 3 Clinical Trials PDF Version On track with U.S. Phase 3 CHIASMA OPTIMAL trial; data now expected by mid-Q3 2019 Target enrollment completed in ongoing Phase 3 MPOWERED™ trial; data expected in 2H 2020 “We are rapidly approaching a potentially transformational milestone for our company, with the anticipated release of CHIASMA OPTIMAL top-*** data that, if positive, will support an NDA filing later this year,” said Raj Kannan, Chief Executive Officer. “As we prepare for commercialization, we are encouraged by the positive feedback we have received from patients, physicians, and scientific experts on the value of an oral treatment alternative to the current standard of care, somatostatin analog injections. We look forward to potential U.S. approval of Mycapssa in mid-2020 as we advance toward our long-term goal of transforming the treatment paradigm for patients with acromegaly in the U.S. and around the world.” http://ir.chiasmapharma.com/news-releases/news-release-details/chiasma-provides-update-ongoing-mycapssar-phase-3-clinical

Uiiii

dunkelrot